The condition is more likely to develop in men with high interleukin-6 or C-reactive protein levels.

Decreased peak flow rate and a history of hypertension and/or diabetes are significantly associated with CKD in men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), according to investigators in Seoul, Korea.

Dutasteride treatment for benign prostatic hyperplasia (BPH) is associated with a significant increase in serum testosterone and a significant decrease in BMI among men with relatively lower baseline serum testosterone levels, researchers reported in BJU International (2009; published online ahead of print).

A study of 602 Korean men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia found that those with a waist circumference greater than 90 cm (central obesity) had a 36% increased risk of severe LUTS compared with men who had smaller waists.

Researchers recently treated the first patients who are participating in a phase 2 clinical trial of a novel therapy for benign prostatic hyperplasia (BPH).

Finasteride treatment reduces the risk of low-grade prostate cancer (PCa) in men taking the drug for symptomatic benign prostatic hyperplasia (BPH), data show.

Use of alfuzosin 10 mg once daily increases the likelihood of a successful trial without catheter (TWOC) after acute urinary retention (AUR) secondary to benign prostatic hyperplasia (BPH), according to researchers.

Æterna Zentaris Inc., of Quebec City, Canada, has announced the opening of an extended phase 3 study of cetrorelix, a treatment for benign prostatic hyperplasia (BPH).

Rapid increases in irritative lower urinary tract symptoms (LUTS) and rapid decreases in peak urinary flow rates may be related to inflammatory processes, new research suggests.

Holmium laser enucleation of the prostate (HoLEP) is a safe alternative to transurethral resection of the prostate (TURP) for patients on oral anticoagulation (OA) therapy, researchers reported in the Journal of Endourology (2009; published online ahead of print).